Qiang Lü

机构：Nanjing Medical University · ORCID：0000-0003-3589-2507

发表论文 183 篇 · 总被引 4546 次 · h-index 31

代表论文

• SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A/BNIP3/mitophagy axis (2025 · Journal of Translational Medicine · 被引 12)
• Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study (2025 · Scientific Reports · 被引 10)
• IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner (2025 · International Journal of Biological Sciences · 被引 10)
• Abstract 4394: GFH375 (VS-7375): An oral, selective KRAS G12D (ON/OFF) inhibitor with potent anti-tumor efficacy as single agent and in combination with other anticancer therapies in preclinical models (2025 · Cancer Research · 被引 8)
• Comparative diagnostic performance of VI-RADS based on biparametric and multiparametric MRI in predicting muscle invasion in bladder cancer (2025 · BMC Medical Imaging · 被引 8)
• Radiomics‐Based Unsupervised Clustering Identifies Subtypes Associated With Prognosis and Immune Microenvironment in Clear Cell Renal Cell Carcinoma: A Multicenter Study (2025 · Advanced Science · 被引 7)